Aandelen in “Fabricage van farmaceutische preparaten”

Aandeel Datum Koers Evolutie
vlag Reata Pharmaceuticals Inc 25/09 172,360 USD
+0,02% 		+0,02%
vlag Redhill Biopharma 16/05 0,483 USD
+4,93% 		+4,93%
vlag Regeneron Pharmaceuticals, Inc. 16/05 967,980 USD
-1,05% 		-1,05%
vlag Regulus Therapeutics Inc 16/05 2,000 USD
-0,99% 		-0,99%
vlag Repare Therapeutics Inc 16/05 3,530 USD
-1,12% 		-1,12%
vlag Revance Therapeutics Inc 16/05 3,160 USD
-4,53% 		-4,53%
vlag Rhythm Pharmaceuticals Inc. 16/05 39,170 USD
-1,09% 		-1,09%
vlag Rigel Pharmaceuticals 16/05 0,983 USD
+1,35% 		+1,35%
vlag Rocket Pharmaceuticals Inc 16/05 23,400 USD
-1,10% 		-1,10%

Nieuws over “Fabricage van farmaceutische preparaten”

05:45 · Seelos Therapeutics Announces Pricing of $1.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules · Persbericht

05:45 · Seelos Therapeutics Announces Pricing of $1.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules · Persbericht

00:50 · AKRO Investors: Reminder - Important Deadline in Securities Fraud Class Action Lawsuit Akero Therapeutics, Inc. · Persbericht

16/05 · Galapagos creates new subscription right plans · Persbericht

16/05 · Galapagos creëert nieuwe inschrijvingsrechtenplannen · Persbericht

16/05 · Moleculin Abstract Accepted for Poster Presentation at the European Hematology Association (EHA) 2024 Hybrid Congress · Persbericht

16/05 · Regulus Therapeutics Announces Promotion of Rekha Garg, M.D., M.S., to Chief Medical Officer · Persbericht

16/05 · Ionis and Biogen Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis · Persbericht

16/05 · Positive Clinical Results from HyBryte™ Compatibility Study in the Treatment of Cutaneous T-Cell Lymphoma Published in JEADV Clinical Practice · Persbericht

16/05 · Carisma Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of CT-0525, a Novel HER2-Targeting CAR-Monocyte · Persbericht

16/05 · Ionis announces positive topline results from Phase 1/2a trial of ION582 for Angelman syndrome · Persbericht

16/05 · With Once-a-Week Dosing, Insulin Efsitora Alfa Delivers A1C Reduction and Safety Profile Consistent with Daily Insulin · Persbericht

15/05 · Galapagos gaat kankertherapie produceren in Amerikaanse bloedcentra · Tijd.be (€)

Het beursgenoteerde Mechelse biotechbedrijf Galapagos gaat samenwerken met Blood Centers of America, het grootste Amerikaanse bloedvoorzieningsnetwerk, om er lokaal zijn gepersonaliseerde kankerbehand...

15/05 · Syndax Pharmaceuticals Appoints Aleksandra Rizo, M.D., Ph.D. to the Board of Directors · Persbericht

15/05 · Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ decentralized CAR-T manufacturing network in the U.S. · Persbericht

15/05 · Galapagos en Blood Centers of America kondigen een strategische samenwerking aan om Galapagos' gedecentraliseerde CAR-T productienetwerk in de VS versneld op te schalen · Persbericht

15/05 · Pulmatrix Announces Peer-Reviewed Publication of Clinical Results for its Orally Inhaled DHE for Acute Migraine (PUR3100) · Persbericht

15/05 · Pulmatrix Announces Peer-Reviewed Publication of Clinical Results for its Orally Inhaled DHE for Acute Migraine (PUR3100) · Persbericht

15/05 · Avidity Biosciences Announces Appointment of Simona Skerjanec to Board of Directors · Persbericht

15/05 · Vanda Pharmaceuticals Reports Positive Results from a Second Phase III Study of Tradipitant in Motion Sickness · Persbericht

15/05 · Moleculin Announces Commencement of NIH-Funded Phase 2 Clinical Trial of STAT3 Inhibitor for the Treatment of Glioblastoma (NU 21C06) · Persbericht

Mijn selecties